Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan

Data on benzodiazepine use in mood disorders are still limited, especially among seniors. A cross‐sectional review of psychotropic prescriptions in 948 outpatients with mood disorders (405 male; mean ± SD age, 52 ± 17 years; age range, 16– 91 years) was conducted in Japan. The use of benzodiazepine‐...

Full description

Saved in:
Bibliographic Details
Published in:Psychiatry and clinical neurosciences 2009-04, Vol.63 (2), p.244-246
Main Authors: Uchida, Hiroyuki, Suzuki, Takefumi, Mamo, David C., Mulsant, Benoit H., Tsunoda, Kenichi, Takeuchi, Hiroyoshi, Kikuchi, Toshiaki, Nakajima, Shinichiro, Nomura, Kensuke, Tomita, Masayuki, Watanabe, Koichiro, Kashima, Haruo
Format: Article
Language:English
Subjects:
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
aging
Anti-Anxiety Agents - therapeutic use
antidepressants
Antidepressive Agents - therapeutic use
benzodiazepine
Benzodiazepines - therapeutic use
Biological and medical sciences
Cross-Sectional Studies
Drug Utilization
Female
Health Care Surveys
Humans
Japan - epidemiology
Male
Medical sciences
Middle Aged
mood disorders
Mood Disorders - drug therapy
Mood Disorders - epidemiology
Mood Disorders - psychology
Neuropharmacology
Outpatients
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Data on benzodiazepine use in mood disorders are still limited, especially among seniors. A cross‐sectional review of psychotropic prescriptions in 948 outpatients with mood disorders (405 male; mean ± SD age, 52 ± 17 years; age range, 16– 91 years) was conducted in Japan. The use of benzodiazepine‐derivative anxiolytics was approximately 60% in all decades, including older patients, without a group difference. The frequent use of benzodiazepines is a cause for concern because they are not preferred treatment, given their well‐known adverse effects especially in the elderly.
ISSN:1323-1316
1440-1819
DOI:10.1111/j.1440-1819.2008.01920.x